O	O	O	0	12	Constitutive	Constitutive	B-NP	JJ	O	2	NMOD	O
O	O	O	13	23	activation	activation	I-NP	NN	O	0	ROOT	O
O	O	O	24	26	of	of	B-PP	IN	O	2	NMOD	O
T18	B-Entity	B-Entity	27	29	NF	NF	B-NP	NN	B-protein	6	NMOD	B-protein
T18	I-Entity	I-Entity	29	30	-	-	O	HYPH	I-protein	6	NMOD	I-protein
T18	I-Entity	I-Entity	30	36	kappaB	kappaB	B-NP	NN	I-protein	3	PMOD	I-protein
O	O	O	37	39	in	in	B-PP	IN	O	2	NMOD	O
O	O	O	40	47	primary	primary	B-NP	JJ	B-cell_type	14	NMOD	B-cell_type
O	O	O	48	53	adult	adult	I-NP	JJ	I-cell_type	14	NMOD	I-cell_type
O	O	O	54	55	T	T	I-NP	NN	I-cell_type	14	NMOD	I-cell_type
O	O	O	55	56	-	-	B-NP	HYPH	I-cell_type	14	NMOD	I-cell_type
O	O	O	56	60	cell	cell	I-NP	NN	I-cell_type	14	NMOD	I-cell_type
O	O	O	61	69	leukemia	leukemia	I-NP	NN	I-cell_type	14	NMOD	I-cell_type
O	O	O	70	75	cells	cell	I-NP	NNS	I-cell_type	7	PMOD	I-cell_type
O	O	O	75	76	.	.	O	.	O	2	P	O

O	O	O	78	83	Human	Human	B-NP	JJ	O	0	ROOT	O
O	O	O	84	85	T	T	I-NP	NN	O	1	NMOD	O
O	O	O	85	86	-	-	I-NP	HYPH	O	2	VMOD	O
O	O	O	86	90	cell	cell	I-NP	NN	O	7	NMOD	O
O	O	O	91	99	leukemia	leukemia	I-NP	NN	O	7	NMOD	O
O	O	O	100	105	virus	virus	I-NP	NN	O	7	NMOD	O
O	O	O	106	110	type	type	I-NP	NN	O	14	SUB	O
O	O	O	111	112	I	I	I-NP	CD	O	7	NMOD	O
O	O	O	113	114	(	(	O	(	O	13	DEP	O
O	O	O	114	118	HTLV	HTLV	B-NP	NN	O	12	NMOD	O
O	O	O	118	119	-	-	B-NP	HYPH	O	12	P	O
O	O	O	119	120	I	I	I-NP	NN	O	13	DEP	O
O	O	O	120	121	)	)	O	)	O	7	NMOD	O
O	O	O	122	124	is	be	B-VP	VBZ	O	3	SBAR	O
O	O	O	125	127	an	an	B-NP	DT	O	17	NMOD	O
O	O	O	128	137	etiologic	etiologic	I-NP	JJ	O	17	NMOD	O
O	O	O	138	143	agent	agent	I-NP	NN	O	14	PRD	O
O	O	O	144	146	of	of	B-PP	IN	O	17	NMOD	O
O	O	O	147	152	adult	adult	B-NP	JJ	O	23	NMOD	O
O	O	O	153	154	T	T	I-NP	NN	O	23	NMOD	O
O	O	O	154	155	-	-	B-NP	HYPH	O	23	NMOD	O
O	O	O	155	159	cell	cell	I-NP	NN	O	23	NMOD	O
O	O	O	160	168	leukemia	leukemia	I-NP	NN	O	18	PMOD	O
O	O	O	169	170	(	(	O	(	O	26	DEP	O
O	O	O	170	173	ATL	ATL	B-NP	NN	O	26	DEP	O
O	O	O	173	174	)	)	O	)	O	23	NMOD	O
O	O	O	174	175	.	.	O	.	O	1	P	O

O	O	O	176	179	The	The	B-NP	DT	O	4	NMOD	O
O	O	O	180	185	viral	viral	I-NP	JJ	B-protein	3	NMOD	B-protein
O	O	O	186	193	protein	protein	I-NP	NN	I-protein	4	NMOD	I-protein
T1	B-Protein	B-Protein	194	197	Tax	Tax	I-NP	NN	B-protein	5	SUB	B-protein
O	O	O	198	205	induces	induce	B-VP	VBZ	O	0	ROOT	O
O	O	O	206	209	the	the	B-NP	DT	O	10	NMOD	O
O	O	O	210	220	activation	activation	I-NP	NN	O	10	NMOD	O
O	O	O	221	224	and	and	O	CC	O	10	NMOD	O
O	O	O	225	232	nuclear	nuclear	B-NP	JJ	O	10	NMOD	O
O	O	O	233	250	translocalization	translocalization	I-NP	NN	O	5	OBJ	O
O	O	O	251	253	of	of	B-PP	IN	O	10	NMOD	O
O	O	O	254	267	transcription	transcription	B-NP	NN	B-protein	13	NMOD	B-protein
O	O	O	268	274	factor	factor	I-NP	NN	I-protein	16	NMOD	I-protein
T19	B-Entity	B-Entity	275	277	NF	NF	I-NP	NN	B-protein	16	NMOD	B-protein
T19	I-Entity	I-Entity	277	278	-	-	B-NP	HYPH	I-protein	16	NMOD	I-protein
T19	I-Entity	I-Entity	278	284	kappaB	kappaB	I-NP	NN	I-protein	11	PMOD	I-protein
O	O	O	284	285	,	,	O	,	O	10	P	O
O	O	O	286	291	which	which	B-NP	WDT	O	10	NMOD	O
O	O	O	292	294	is	be	B-VP	VBZ	O	18	SBAR	O
O	O	O	295	303	proposed	propose	I-VP	VBN	O	19	VC	O
O	O	O	304	306	to	to	I-VP	TO	O	22	VMOD	O
O	O	O	307	311	play	play	I-VP	VB	O	20	VMOD	O
O	O	O	312	313	a	a	B-NP	DT	O	25	NMOD	O
O	O	O	314	321	crucial	crucial	I-NP	JJ	O	25	NMOD	O
O	O	O	322	326	role	role	I-NP	NN	O	22	OBJ	O
O	O	O	327	329	in	in	B-PP	IN	O	22	VMOD	O
O	O	O	330	333	the	the	B-NP	DT	O	28	NMOD	O
O	O	O	334	348	transformation	transformation	I-NP	NN	O	26	PMOD	O
O	O	O	349	351	of	of	B-PP	IN	O	28	NMOD	O
O	O	O	352	353	T	T	B-NP	NN	B-cell_type	31	NMOD	B-cell_type
O	O	O	354	359	cells	cell	I-NP	NNS	I-cell_type	29	PMOD	I-cell_type
O	O	O	360	362	by	by	B-PP	IN	O	28	NMOD	O
O	O	O	363	367	HTLV	HTLV	B-NP	NN	B-protein	35	NMOD	B-protein
O	O	O	367	368	-	-	I-NP	HYPH	O	35	P	O
O	O	O	368	369	I	I	I-NP	NN	O	32	PMOD	O
O	O	O	369	370	.	.	O	.	O	5	P	O

O	O	O	371	378	However	However	B-ADVP	RB	O	10	VMOD	O
O	O	O	378	379	,	,	O	,	O	10	P	O
O	O	O	380	383	the	the	B-NP	DT	O	7	NMOD	O
T20	B-Entity	B-Entity	384	388	HTLV	HTLV	I-NP	NN	B-protein	7	NMOD	B-protein
T20	I-Entity	I-Entity	388	389	-	-	B-NP	HYPH	O	7	NMOD	O
T20	I-Entity	I-Entity	389	390	I	I	I-NP	NN	B-DNA	7	NMOD	B-DNA
T20	I-Entity	I-Entity	391	396	genes	gene	I-NP	NNS	I-DNA	10	SUB	I-DNA
O	O	O	397	406	including	include	B-PP	VBG	O	7	NMOD	O
T2	B-Protein	B-Protein	407	410	Tax	Tax	B-NP	NN	B-protein	8	PMOD	B-protein
O	O	O	411	414	are	be	B-VP	VBP	O	0	ROOT	O
O	O	O	415	418	not	not	I-VP	RB	O	10	VMOD	O
O	O	O	419	428	expressed	express	I-VP	VBN	O	10	VC	O
O	O	O	429	442	significantly	significantly	B-ADVP	RB	O	12	VMOD	O
O	O	O	443	445	in	in	B-PP	IN	O	12	VMOD	O
O	O	O	446	453	primary	primary	B-NP	JJ	B-cell_type	17	NMOD	B-cell_type
O	O	O	454	462	leukemic	leukemic	I-NP	JJ	I-cell_type	17	NMOD	I-cell_type
O	O	O	463	468	cells	cell	I-NP	NNS	I-cell_type	14	PMOD	I-cell_type
O	O	O	469	473	from	from	B-PP	IN	O	17	NMOD	O
O	O	O	474	477	ATL	ATL	B-NP	NN	O	20	NMOD	O
O	O	O	478	486	patients	patient	I-NP	NNS	O	18	PMOD	O
O	O	O	486	487	.	.	O	.	O	10	P	O

O	O	O	488	490	In	In	B-PP	IN	O	6	VMOD	O
O	O	O	491	495	this	this	B-NP	DT	O	3	NMOD	O
O	O	O	496	501	study	study	I-NP	NN	O	1	PMOD	O
O	O	O	501	502	,	,	O	,	O	6	P	O
O	O	O	503	505	we	we	B-NP	PRP	O	6	SUB	O
O	O	O	506	514	examined	examine	B-VP	VBD	O	0	ROOT	O
O	O	O	515	518	the	the	B-NP	DT	O	8	NMOD	O
O	O	O	519	524	basis	basis	I-NP	NN	O	6	OBJ	O
O	O	O	525	528	for	for	B-PP	IN	O	8	NMOD	O
T21	B-Entity	B-Entity	529	531	NF	NF	B-NP	NN	B-protein	12	NMOD	B-protein
T21	I-Entity	I-Entity	531	532	-	-	B-NP	HYPH	I-protein	12	NMOD	I-protein
T21	I-Entity	I-Entity	532	538	kappaB	kappaB	I-NP	NN	I-protein	13	NMOD	I-protein
O	O	O	539	549	activation	activation	I-NP	NN	O	9	PMOD	O
O	O	O	550	552	in	in	B-PP	IN	O	13	NMOD	O
O	O	O	553	560	freshly	freshly	B-NP	RB	B-cell_type	18	NMOD	B-cell_type
O	O	O	561	569	isolated	isolate	I-NP	VBN	I-cell_type	18	NMOD	I-cell_type
O	O	O	570	578	leukemic	leukemic	I-NP	JJ	I-cell_type	18	NMOD	I-cell_type
O	O	O	579	584	cells	cell	I-NP	NNS	I-cell_type	14	PMOD	I-cell_type
O	O	O	585	589	from	from	B-PP	IN	O	18	NMOD	O
O	O	O	590	593	ATL	ATL	B-NP	NN	O	21	NMOD	O
O	O	O	594	602	patients	patient	I-NP	NNS	O	19	PMOD	O
O	O	O	602	603	.	.	O	.	O	6	P	O

O	O	O	604	606	We	We	B-NP	PRP	O	2	SUB	O
O	O	O	607	612	found	find	B-VP	VBD	O	0	ROOT	O
O	O	O	613	617	that	that	B-SBAR	IN	O	2	VMOD	O
O	O	O	618	626	leukemic	leukemic	B-NP	JJ	B-cell_type	5	NMOD	B-cell_type
O	O	O	627	632	cells	cell	I-NP	NNS	I-cell_type	21	SUB	I-cell_type
O	O	O	633	637	from	from	B-PP	IN	O	5	NMOD	O
O	O	O	638	641	ATL	ATL	B-NP	NN	O	8	NMOD	O
O	O	O	642	650	patients	patient	I-NP	NNS	O	6	PMOD	O
O	O	O	650	651	,	,	O	,	O	5	P	O
O	O	O	652	656	like	like	B-PP	IN	O	21	VMOD	O
O	O	O	657	661	HTLV	HTLV	B-NP	NN	B-cell_line	19	NMOD	B-cell_line
O	O	O	661	662	-	-	B-NP	HYPH	I-cell_line	19	NMOD	I-cell_line
O	O	O	662	663	I	I	I-NP	NN	I-cell_line	19	NMOD	I-cell_line
O	O	O	663	664	-	-	B-NP	HYPH	I-cell_line	19	NMOD	I-cell_line
O	O	O	664	672	infected	infect	I-NP	VBN	I-cell_line	19	NMOD	I-cell_line
O	O	O	673	674	T	T	I-NP	NN	I-cell_line	19	NMOD	I-cell_line
O	O	O	674	675	-	-	I-NP	HYPH	I-cell_line	19	NMOD	I-cell_line
O	O	O	675	679	cell	cell	I-NP	NN	I-cell_line	19	NMOD	I-cell_line
O	O	O	680	685	lines	line	I-NP	NNS	I-cell_line	10	PMOD	I-cell_line
O	O	O	685	686	,	,	O	,	O	21	P	O
O	O	O	687	694	display	display	B-VP	VBP	O	3	SBAR	O
O	O	O	695	707	constitutive	constitutive	B-NP	JJ	O	28	NMOD	O
T22	B-Entity	B-Entity	708	710	NF	NF	I-NP	NN	B-protein	25	NMOD	B-protein
T22	I-Entity	I-Entity	710	711	-	-	B-NP	HYPH	I-protein	25	NMOD	I-protein
T22	I-Entity	I-Entity	711	717	kappaB	kappaB	I-NP	NN	I-protein	28	NMOD	I-protein
T23	I-Entity	I-Entity	718	721	DNA	DNA	I-NP	NN	O	28	NMOD	O
O	O	O	722	729	binding	binding	I-NP	NN	O	28	NMOD	O
O	O	O	730	738	activity	activity	I-NP	NN	O	31	NMOD	O
O	O	O	739	742	and	and	O	CC	O	31	NMOD	O
O	O	O	743	752	increased	increase	B-NP	VBN	O	31	NMOD	O
O	O	O	753	764	degradation	degradation	I-NP	NN	O	21	OBJ	O
O	O	O	765	767	of	of	B-PP	IN	O	31	NMOD	O
T3	B-Protein	B-Protein	768	780	IkappaBalpha	IkappaBalpha	B-NP	NN	B-protein	32	PMOD	B-protein
O	O	O	781	782	(	(	O	(	O	41	DEP	O
O	O	O	782	784	an	an	B-NP	DT	O	36	NMOD	O
O	O	O	785	794	inhibitor	inhibitor	I-NP	NN	O	41	DEP	O
O	O	O	795	797	of	of	B-PP	IN	O	36	NMOD	O
T24	B-Entity	B-Entity	798	800	NF	NF	B-NP	NN	B-protein	40	NMOD	B-protein
T24	I-Entity	I-Entity	800	801	-	-	B-NP	HYPH	I-protein	40	NMOD	I-protein
T24	I-Entity	I-Entity	801	807	kappaB	kappaB	I-NP	NN	I-protein	37	PMOD	I-protein
O	O	O	807	808	)	)	O	)	O	33	NMOD	O
O	O	O	808	809	.	.	O	.	O	2	P	O

O	O	O	810	817	Whereas	Whereas	B-SBAR	IN	O	0	ROOT	O
O	O	O	818	821	the	the	B-NP	DT	O	7	NMOD	O
T25	B-Entity	B-Entity	822	824	NF	NF	I-NP	NN	B-protein	5	NMOD	B-protein
T25	I-Entity	I-Entity	824	825	-	-	B-NP	HYPH	I-protein	5	NMOD	I-protein
T25	I-Entity	I-Entity	825	831	kappaB	kappaB	I-NP	NN	I-protein	7	NMOD	I-protein
O	O	O	832	839	binding	binding	I-NP	NN	O	7	NMOD	O
O	O	O	840	848	activity	activity	I-NP	NN	O	16	SUB	O
O	O	O	849	851	in	in	B-PP	IN	O	7	NMOD	O
T4	B-Protein	B-Protein	852	855	Tax	Tax	B-NP	NN	B-cell_line	15	NMOD	B-cell_line
O	O	O	855	856	-	-	B-PP	HYPH	I-cell_line	15	NMOD	I-cell_line
O	O	O	856	866	expressing	express	B-NP	VBG	I-cell_line	15	NMOD	I-cell_line
O	O	O	867	868	T	T	I-NP	NN	I-cell_line	15	NMOD	I-cell_line
O	O	O	868	869	-	-	I-NP	HYPH	I-cell_line	15	NMOD	I-cell_line
O	O	O	869	873	cell	cell	I-NP	NN	I-cell_line	15	NMOD	I-cell_line
O	O	O	874	879	lines	line	I-NP	NNS	I-cell_line	8	PMOD	I-cell_line
O	O	O	880	889	consisted	consist	B-VP	VBD	O	1	SBAR	O
O	O	O	890	896	mostly	mostly	B-ADVP	RB	O	18	PMOD	O
O	O	O	897	899	of	of	B-PP	IN	O	16	VMOD	O
T5,T26	B-Protein,B-Entity	B-Protein,B-Entity	900	903	p50	p50	B-NP	NN	B-protein	23	NMOD	B-protein
T26	I-Entity	I-Entity	903	904	/	/	B-NP	SYM	O	23	NMOD	O
T6,T26	B-Protein,I-Entity	B-Protein,I-Entity	904	905	c	c	I-NP	NN	B-protein	23	NMOD	B-protein
T6,T26	I-Protein,I-Entity	I-Protein,I-Entity	905	906	-	-	B-NP	HYPH	I-protein	23	NMOD	I-protein
T6,T26	I-Protein,I-Entity	I-Protein,I-Entity	906	909	Rel	Rel	I-NP	NN	I-protein	27	NMOD	I-protein
O	O	O	909	910	,	,	O	,	O	27	P	O
O	O	O	911	916	fresh	fresh	B-NP	JJ	O	27	NMOD	O
O	O	O	917	920	ATL	ATL	I-NP	NN	O	27	NMOD	O
O	O	O	921	928	samples	sample	I-NP	NNS	O	18	PMOD	O
O	O	O	929	938	contained	contain	B-VP	VBD	O	16	VMOD	O
T7	B-Protein	B-Protein	939	942	p50	p50	B-NP	NN	B-protein	36	NMOD	B-protein
O	O	O	942	943	/	/	O	SYM	O	36	P	O
T8	B-Protein	B-Protein	943	946	p50	p50	B-NP	NN	B-protein	36	NMOD	B-protein
O	O	O	947	950	and	and	O	CC	O	36	NMOD	O
T9	B-Protein	B-Protein	951	954	p50	p50	B-NP	NN	B-protein	36	NMOD	B-protein
O	O	O	954	955	/	/	O	SYM	O	36	P	O
T10	B-Protein	B-Protein	955	958	p65	p65	B-NP	NN	B-protein	36	NMOD	B-protein
T27	B-Entity	B-Entity	959	971	heterodimers	heterodimer	I-NP	NNS	I-protein	28	OBJ	I-protein
O	O	O	971	972	.	.	O	.	O	1	P	O

O	O	O	973	976	One	One	B-NP	CD	O	5	NMOD	O
O	O	O	977	978	T	T	I-NP	NN	B-cell_line	5	NMOD	B-cell_line
O	O	O	978	979	-	-	I-NP	HYPH	I-cell_line	5	NMOD	I-cell_line
O	O	O	979	983	cell	cell	I-NP	NN	I-cell_line	5	NMOD	I-cell_line
O	O	O	984	988	line	line	I-NP	NN	I-cell_line	14	NMOD	I-cell_line
O	O	O	989	996	derived	derive	B-VP	VBN	O	5	NMOD	O
O	O	O	997	1001	from	from	B-PP	IN	O	6	VMOD	O
O	O	O	1002	1005	ATL	ATL	B-NP	NN	O	10	NMOD	O
O	O	O	1006	1014	leukemic	leukemic	I-NP	JJ	B-cell_type	10	NMOD	B-cell_type
O	O	O	1015	1020	cells	cell	I-NP	NNS	I-cell_type	7	PMOD	I-cell_type
O	O	O	1020	1021	,	,	O	,	O	14	P	O
O	O	O	1022	1024	TL	TL	B-NP	NN	O	14	NMOD	O
O	O	O	1024	1025	-	-	B-NP	HYPH	O	14	NMOD	O
O	O	O	1025	1028	Om1	Om1	I-NP	NN	B-protein	16	SUB	B-protein
O	O	O	1028	1029	,	,	O	,	O	14	P	O
O	O	O	1030	1039	displayed	display	B-VP	VBD	O	0	ROOT	O
O	O	O	1040	1052	constitutive	constitutive	B-NP	JJ	O	21	NMOD	O
T28	B-Entity	B-Entity	1053	1055	NF	NF	I-NP	NN	B-protein	21	NMOD	B-protein
T28	I-Entity	I-Entity	1055	1056	-	-	B-NP	HYPH	I-protein	21	NMOD	I-protein
T28	I-Entity	I-Entity	1056	1062	kappaB	kappaB	I-NP	NN	I-protein	21	NMOD	I-protein
O	O	O	1063	1071	activity	activity	I-NP	NN	O	27	NMOD	O
O	O	O	1071	1072	,	,	O	,	O	27	P	O
O	O	O	1073	1075	as	as	B-CONJP	RB	O	27	NMOD	O
O	O	O	1076	1080	well	well	I-CONJP	RB	O	23	DEP	O
O	O	O	1081	1083	as	as	I-CONJP	IN	O	23	DEP	O
O	O	O	1084	1092	enhanced	enhance	B-NP	VBN	O	27	NMOD	O
O	O	O	1093	1104	degradation	degradation	I-NP	NN	O	16	OBJ	O
O	O	O	1105	1107	of	of	B-PP	IN	O	27	NMOD	O
T11	B-Protein	B-Protein	1108	1120	IkappaBalpha	IkappaBalpha	B-NP	NN	B-protein	28	PMOD	B-protein
O	O	O	1120	1121	,	,	O	,	O	16	P	O
O	O	O	1122	1129	despite	despite	B-PP	IN	O	16	VMOD	O
O	O	O	1130	1133	the	the	B-NP	DT	O	33	NMOD	O
O	O	O	1134	1138	lack	lack	I-NP	NN	O	31	PMOD	O
O	O	O	1139	1141	of	of	B-PP	IN	O	33	NMOD	O
O	O	O	1142	1152	detectable	detectable	B-NP	JJ	O	37	NMOD	O
T12	B-Protein	B-Protein	1153	1156	Tax	Tax	I-NP	NN	B-protein	37	NMOD	B-protein
O	O	O	1157	1167	expression	expression	I-NP	NN	O	34	PMOD	O
O	O	O	1167	1168	.	.	O	.	O	16	P	O

O	O	O	1169	1182	Interestingly	Interestingly	B-ADVP	RB	O	11	VMOD	O
O	O	O	1182	1183	,	,	O	,	O	11	P	O
O	O	O	1184	1187	the	the	B-NP	DT	O	6	NMOD	O
T29	B-Entity	B-Entity	1188	1190	NF	NF	I-NP	NN	B-protein	6	NMOD	B-protein
T29	I-Entity	I-Entity	1190	1191	-	-	O	HYPH	I-protein	6	NMOD	I-protein
T29	I-Entity	I-Entity	1191	1197	kappaB	kappaB	B-NP	NN	I-protein	11	SUB	I-protein
O	O	O	1198	1200	in	in	B-PP	IN	O	6	NMOD	O
O	O	O	1201	1203	TL	TL	B-NP	NN	B-cell_type	10	NMOD	B-cell_type
O	O	O	1203	1204	-	-	B-NP	HYPH	O	10	NMOD	O
O	O	O	1204	1207	Om1	Om1	I-NP	NN	B-protein	7	PMOD	B-protein
O	O	O	1208	1216	consists	consist	B-VP	VBZ	O	0	ROOT	O
O	O	O	1217	1219	of	of	B-PP	IN	O	11	VMOD	O
T13,T30	B-Protein,B-Entity	B-Protein,B-Entity	1220	1223	p50	p50	B-NP	NN	B-protein	19	NMOD	B-protein
T30	I-Entity	I-Entity	1223	1224	/	/	O	SYM	O	19	P	O
T14,T30	B-Protein,I-Entity	B-Protein,I-Entity	1224	1227	p50	p50	B-NP	NN	B-protein	19	NMOD	B-protein
O	O	O	1228	1231	and	and	O	CC	O	19	NMOD	O
T15,T31	B-Protein,B-Entity	B-Protein,B-Entity	1232	1235	p50	p50	B-NP	NN	B-protein	19	NMOD	B-protein
T31	I-Entity	I-Entity	1235	1236	/	/	O	SYM	O	19	P	O
T16,T31	B-Protein,I-Entity	B-Protein,I-Entity	1236	1239	p65	p65	B-NP	NN	B-protein	12	PMOD	B-protein
O	O	O	1240	1244	like	like	B-PP	IN	O	11	VMOD	O
O	O	O	1245	1249	that	that	B-NP	DT	O	20	PMOD	O
O	O	O	1250	1252	in	in	B-PP	IN	O	21	NMOD	O
O	O	O	1253	1258	fresh	fresh	B-NP	JJ	O	26	NMOD	O
O	O	O	1259	1266	primary	primary	I-NP	JJ	B-cell_type	26	NMOD	B-cell_type
O	O	O	1267	1275	leukemic	leukemic	I-NP	JJ	I-cell_type	26	NMOD	I-cell_type
O	O	O	1276	1281	cells	cell	I-NP	NNS	I-cell_type	22	PMOD	I-cell_type
O	O	O	1281	1282	.	.	O	.	O	11	P	O

O	O	O	1283	1286	Our	Our	B-NP	PRP$	O	2	NMOD	O
O	O	O	1287	1294	results	result	I-NP	NNS	O	3	SUB	O
O	O	O	1295	1302	suggest	suggest	B-VP	VBP	O	0	ROOT	O
O	O	O	1303	1307	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	O	1308	1318	activation	activation	B-NP	NN	O	10	SUB	O
O	O	O	1319	1321	of	of	B-PP	IN	O	5	NMOD	O
T32	B-Entity	B-Entity	1322	1324	NF	NF	B-NP	NN	B-protein	9	NMOD	B-protein
T32	I-Entity	I-Entity	1324	1325	-	-	B-NP	HYPH	I-protein	9	NMOD	I-protein
T32	I-Entity	I-Entity	1325	1331	kappaB	kappaB	I-NP	NN	I-protein	6	PMOD	I-protein
O	O	O	1332	1338	occurs	occur	B-VP	VBZ	O	4	SBAR	O
O	O	O	1339	1346	through	through	B-PP	IN	O	10	VMOD	O
O	O	O	1347	1348	a	a	B-NP	DT	O	16	NMOD	O
T17	B-Protein	B-Protein	1349	1352	Tax	Tax	I-NP	NN	B-protein	16	NMOD	B-protein
O	O	O	1352	1353	-	-	B-NP	HYPH	O	16	NMOD	O
O	O	O	1353	1364	independent	independent	I-NP	JJ	O	16	NMOD	O
O	O	O	1365	1374	mechanism	mechanism	I-NP	NN	O	11	PMOD	O
O	O	O	1375	1377	in	in	B-PP	IN	O	16	NMOD	O
O	O	O	1378	1386	leukemic	leukemic	B-NP	JJ	B-cell_type	19	NMOD	B-cell_type
O	O	O	1387	1392	cells	cell	I-NP	NNS	I-cell_type	17	PMOD	I-cell_type
O	O	O	1393	1395	of	of	B-PP	IN	O	19	NMOD	O
O	O	O	1396	1399	ATL	ATL	B-NP	NN	O	22	NMOD	O
O	O	O	1400	1408	patients	patient	I-NP	NNS	O	20	PMOD	O
O	O	O	1408	1409	,	,	O	,	O	10	P	O
O	O	O	1410	1418	possibly	possibly	B-ADVP	RB	O	26	PMOD	O
O	O	O	1419	1422	due	due	B-PP	JJ	O	26	PMOD	O
O	O	O	1423	1425	to	to	B-PP	TO	O	10	VMOD	O
O	O	O	1426	1438	differential	differential	B-NP	JJ	O	32	NMOD	O
T33	B-Entity	B-Entity	1439	1441	NF	NF	I-NP	NN	O	32	NMOD	O
T33	I-Entity	I-Entity	1441	1442	-	-	B-NP	HYPH	O	32	NMOD	O
T33	I-Entity	I-Entity	1442	1448	kappaB	kappaB	I-NP	NN	B-protein	31	NMOD	B-protein
O	O	O	1449	1456	subunit	subunit	I-NP	NN	I-protein	32	NMOD	I-protein
O	O	O	1457	1467	activation	activation	I-NP	NN	O	26	PMOD	O
O	O	O	1467	1468	.	.	O	.	O	3	P	O
